Recent News

• 02.05.2026 - Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
• 01.08.2026 - Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T
• 12.15.2025 - Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis

Recent Filings

• 02.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 02.02.2026 - 144 Report of proposed sale of securities
• 02.02.2026 - 144 Report of proposed sale of securities
• 02.02.2026 - 144 Report of proposed sale of securities